↓ Skip to main content
Altmetric
What is this page?
Embed badge
Share
Share on Twitter
Share on Facebook
Share by email
Evaluating the effects of the novel GLP-1 analogue liraglutide in Alzheimer’s disease: study protocol for a randomised controlled trial (ELAD study)
Overview of attention for article published in Trials, April 2019
Altmetric Badge
Mentioned by
blogs
1
blog
twitter
14
X users
patent
1
patent
Citations
dimensions_citation
130
Dimensions
Readers on
mendeley
270
Mendeley
Summary
Blogs
X
Patents
Dimensions citations
So far, Altmetric has seen
1
patent that references this research output.
THERAPEUTIC USES OF DULAGLUTIDE
Application EP-4096704-A4
European Patent Office
31 Jan 2024